Table 3.
Pre- and post-treatment characteristics (before induction and at the end of maintenance) of patients with a relapse compared with those in remission
| Relapse (n = 11) | Remission (n = 9) | P value | ||||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| Endoscopic findings [n (%)] | ||||||
| Normal | 0 (0) | 6 (55) | 0 (0) | 8 (89) | NS | 0.09 |
| Rings | 4 (36) | 1 (9) | 3 (33) | 1 (11) | NS | NS |
| Exudates | 10 (91) | 1 (9) | 7 (78) | 1 (11) | NS | NS |
| Furrows | 8 (73) | 3 (27) | 7 (78) | 1 (11) | NS | NS |
| Edema | 4 (37) | 2 (18) | 5 (56) | 1 (11) | NS | NS |
| Stricture | 0 (0) | 0 (0) | 0 (0) | 0 (0) | NS | NS |
| Total EREFS (mean ± SD) | 4.4 ± 1.2 | 0.8 ± 1.2 | 4.1 ± 1.3 | 0.1 ± 0.3 | NS | 0.09 |
| Symptoms score (mean ± SD) | 5.1 ± 2.8 | 1.1 ± 1.9 | 3.4 ± 2.5 | 0.1 ± 0.3 | NS | NS |
| Peak eosinophil count (mean ± SD) | 46.8 ± 13.1 | 4.7 ± 7.4 | 52.7 ± 25.8 | 0.3 ± 1 | NS | 0.09 |
| Histology score (mean ± SD) | 9.5 ± 1.6 | 2.5 ± 2.7 | 8.9 ± 1.7 | 0.6 ± 1.1 | NS | 0.08 |
| Compliance (mean %) | – | 95 | – | 97 | – | NS |